The renin-angiotensin system (RAS) is one further explanation for the beneficial effects of LPD in diabetic nephropathy as it is considered to be involved in most of the pathological processes that result in diabetic nephropathy. The gene discussed is REN; the disease is disseminated peritoneal leiomyomatosis.